Commodity | Reporter | Partner | Trade flow | Indicator | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | Ireland | World | Exports | Value (US$) | 8,615,244,979.00 | 8,467,959,528.00 | 5,734,466,096.30 | 5,961,806,728.99 | 8,724,542,831.08 | 10,715,929,410.94 | 19,924,374,114.03 | 30,627,934,042.14 | 34,405,054,121.07 | 41,701,585,723.49 | 43,753,612,249.90 | 48,517,181,337.83 |
Value Growth, YoY (%) | 47.78 | -1.70 | -32.28 | 3.96 | 46.34 | 22.82 | 85.93 | 53.72 | 12.33 | 21.20 | 4.92 | 10.88 | ||||
Imports | Value (US$) | 546,103,188.00 | 514,385,183.00 | 450,746,704.83 | 825,795,695.51 | 1,026,556,095.44 | 2,039,306,436.14 | 4,662,770,825.72 | 3,182,904,867.65 | 3,175,158,329.25 | 3,970,999,402.56 | 5,467,310,372.80 | 6,058,827,560.41 | |||
Value Growth, YoY (%) | 26.24 | -5.80 | -12.37 | 83.20 | 24.31 | 98.65 | 128.64 | -31.73 | -0.24 | 25.06 | 37.68 | 10.81 |
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland totalled $ 48 billion in 2022. Sales of commodity group 3002 from Ireland went up by 10.8% compared to 2021: exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 4.76 billion (cumulative exports of commodity group 3002 from Ireland amounted $43 billion in 2021)
Exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" amounted to 22% of total exports from Ireland (cumulative merchandise exports from Ireland totalled $ 219 billion in 2022). The share of commodity group 3002 in total exports from Ireland decreased by 0.219 p.p. compared to 2021 (it was 22% in 2021 and cumulative exports from Ireland were equal to $ 195 billion).
Exports of commodity group 3002 amounted to 64% of total sales of group "" from Ireland in 2022 (the value of exports of commodity group from Ireland amounted to $75 billion in 2022). The share of exports of commodity group 3002 in sales of commodity group from Ireland lowered by 0.575 p.p. compared to 2021 (it was 64% in 2021, and exports of commodity group from Ireland were $67 billion).
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Ireland in 2022:
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Ireland totalled $ 6.05 billion in 2022. Sales of commodity group 3002 to Ireland went up by 10.8% compared to 2021: imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 591 million (the value of imports of commodity group 3002 to Ireland was equal to $5.46 billion in 2021)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 4.07% of total import flow to Ireland (in 2022, total imports to Ireland amounted to $ 148 billion). The share of commodity group 3002 in total imports to Ireland decreased by 0.377 p.p. compared to 2021 (it was 4.45% in 2021 and cumulative imports to Ireland were equal to $ 122 billion).
Imports of commodity group 3002 reached 52% of total imports of group "" to Ireland in 2022 (imports of commodity group to Ireland totalled $11.6 billion in 2022). The share of purchases of commodity group 3002 in total imports of commodity group to Ireland increased by 2.11 p.p. compared to 2021 (it was 49% in 2021, and imports of commodity group to Ireland accounted for $10.9 billion).
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of Ireland in 2022: